Orum Therapeutics, Inc. (475830) Price & Analysis

― Followers

475830 Stock Chart & Stats

₩68100.00

₩1,200.00(1.79%)

Aug 14, 2026

―

Day’s Range― - ―

52-Week Range₩22,650.00 - ₩146,600.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)191.15K

Market Cap

₩1.45T

Enterprise Value₩1.85M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.38

Next Earnings

Nov 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding21,719,590

10 Day Avg. Volume84,081

30 Day Avg. Volume191,150

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

475830 FAQ

What was Orum Therapeutics, Inc.’s price range in the past 12 months?

Orum Therapeutics, Inc. lowest stock price was ₩22650.00 and its highest was ₩146600.00 in the past 12 months.

What is Orum Therapeutics, Inc.’s market cap?

Orum Therapeutics, Inc.’s market cap is ₩1.45T.

When is Orum Therapeutics, Inc.’s upcoming earnings report date?

Orum Therapeutics, Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 90 days.

How were Orum Therapeutics, Inc.’s earnings last quarter?

Currently, no data Available

Is Orum Therapeutics, Inc. overvalued?

According to Wall Street analysts Orum Therapeutics, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Orum Therapeutics, Inc. pay dividends?

Orum Therapeutics, Inc. does not currently pay dividends.

What is Orum Therapeutics, Inc.’s EPS estimate?

Orum Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Orum Therapeutics, Inc. have?

Orum Therapeutics, Inc. has 21,719,590 shares outstanding.

What happened to Orum Therapeutics, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Orum Therapeutics, Inc.?

Currently, no hedge funds are holding shares in KR:475830

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology